Pure Pharm Peptides

Age Verification Required

Pure Pharm Peptides sells research chemicals intended for laboratory use only.

You must be 18 years of age or older to access this website.

By clicking "I am 18 or Older", you confirm that you meet this age requirement.

FOR RESEARCH USE ONLY
NOT FOR HUMAN CONSUMPTION

This verification will be remembered on this device.

Anti-Aging Research2026-03-0210 min read

GHK-Cu: Copper Peptide Biology and Skin Wound Research

Research Use Only. This article is for scientific and educational reference only. All products are sold for research purposes and are not intended for human or animal consumption.

# GHK-Cu: Copper Peptide Biology and Skin/Wound Research

For Research Purposes Only — Not Intended for Human or Animal Consumption

Introduction

GHK-Cu (glycyl-L-histidyl-L-lysine copper complex) is a naturally occurring copper-binding tripeptide first isolated from human plasma by Loren Pickart in 1973. The peptide has been extensively studied for its roles in wound healing, collagen synthesis, antioxidant defense, and gene expression modulation. Unlike many synthetic peptides, GHK-Cu has a documented presence in human physiology — plasma concentrations decline from approximately 200 ng/mL in young adults to less than 80 ng/mL in elderly individuals, a decline that has been proposed to contribute to age-related impairment in tissue repair.

Copper Binding Chemistry

The biological activity of GHK-Cu depends critically on its ability to bind copper(II) ions. The tripeptide sequence glycyl-L-histidyl-L-lysine has a high affinity for Cu²⁺, with a binding constant (log K) of approximately 16.4 — among the highest of any known tripeptide.

The copper-binding site involves the alpha-amino group of glycine, the imidazole nitrogen of histidine, and the peptide nitrogen of the glycine-histidine bond. This arrangement creates a stable square-planar coordination complex that protects copper from participating in Fenton-type reactions that generate hydroxyl radicals.

This copper sequestration has dual significance: it delivers bioavailable copper to tissues that require it for enzymatic activity (lysyl oxidase, superoxide dismutase, cytochrome c oxidase), while simultaneously preventing copper-catalyzed oxidative damage.

Collagen Synthesis and Remodeling

GHK-Cu's most extensively documented effect is stimulation of collagen synthesis. Wegrowski et al. (1992) demonstrated that GHK-Cu stimulates collagen synthesis in fibroblasts at concentrations as low as 1 nM, with maximal effects at approximately 1 μM. The mechanism involves upregulation of collagen type I and type III gene expression, as well as increased activity of prolyl hydroxylase — the enzyme responsible for collagen cross-linking.

Beyond synthesis, GHK-Cu also modulates collagen remodeling. It stimulates the production of matrix metalloproteinases (MMPs) that degrade damaged collagen, while simultaneously upregulating tissue inhibitors of metalloproteinases (TIMPs) that prevent excessive degradation. This balanced regulation of collagen turnover is proposed to explain GHK-Cu's ability to improve skin texture without causing excessive matrix degradation.

Antioxidant Properties

GHK-Cu exhibits significant antioxidant activity through multiple mechanisms. As noted above, copper sequestration prevents Fenton chemistry. Additionally, GHK-Cu has been shown to upregulate the expression of antioxidant enzymes including superoxide dismutase (SOD) and catalase.

Pickart et al. (2015) demonstrated that GHK-Cu activates the Nrf2 pathway — a master regulator of antioxidant gene expression — in human fibroblasts. Nrf2 activation induces expression of a broad array of cytoprotective genes, providing a mechanistic explanation for GHK-Cu's observed protective effects against oxidative stress.

Wound Healing Research

GHK-Cu has been studied in multiple wound healing models. Pickart and Margolina (2018) reviewed the published literature and identified consistent pro-healing effects across skin, corneal, and gastrointestinal wound models. The proposed mechanisms include:

- Stimulation of keratinocyte and fibroblast migration into the wound bed - Increased collagen and glycosaminoglycan synthesis - Promotion of angiogenesis through VEGF upregulation - Anti-inflammatory effects through downregulation of TNF-α and IL-6

Clinical studies using topical GHK-Cu formulations have demonstrated improvements in wound healing rates and skin quality, though these studies are generally small and methodologically heterogeneous.

Gene Expression Modulation

One of the more striking findings in GHK-Cu research is its broad effects on gene expression. Pickart et al. (2012) used gene microarray analysis to demonstrate that GHK-Cu modulates the expression of over 4,000 human genes — approximately 31% of the genome. The affected genes are enriched for pathways related to tissue remodeling, inflammation, cell migration, and DNA repair.

This broad gene expression effect has been proposed as the mechanistic basis for GHK-Cu's diverse biological activities, though the upstream signaling pathways responsible for such widespread transcriptional changes remain incompletely characterized.

References

  1. Pickart, L. (1973). Human plasma fractions with growth-promoting activity. Journal of Clinical Investigation, 52(12), 2979–2984.
  2. Wegrowski, Y., et al. (1992). The effect of glycyl-L-histidyl-L-lysine copper complex on collagen and glycosaminoglycan synthesis by human fibroblasts. Life Sciences, 51(13), 1049–1056.
  3. Pickart, L., & Margolina, A. (2018). Regenerative and Protective Actions of the GHK-Cu Peptide in the Light of the New Gene Data. International Journal of Molecular Sciences, 19(7), 1987.
  4. Pickart, L., et al. (2015). GHK Peptide as a Natural Modulator of Multiple Cellular Pathways in Skin Regeneration. BioMed Research International, 2015, 648108.

Research Grade Available

Pure Pharm Peptides offers research-grade GHK-Cu with ≥99% HPLC purity, independently verified by third-party laboratories.